WASHINGTON, Dec. 21, 2004 (PRIMEZONE) -- Healthnostics, Inc. (Pink Sheets:HNST), a medical and bioscience information analytics and patient care improvement company, today announced a multi-year partnership agreement with Valeo IP, the leading Internet-based digital licensing and intellectual property management company, for the purchase of digital files, permissions and hard-copy reprints (including PDFs) directly online from licensed content within the Healthnostics www.MedBioWorld.com Internet portal site. The Valeo IP service gives medical and bioscience users of the MedBioWorld web site the ability to find, clear and use news and medical/bioscience journal articles and other content items discovered within locally archived databases using the recently announced semantic search engine from Healthnostics.
"Valeo IP provides us with very efficient and legal web-based document clearance technology for our partners licensed and copyrighted content. Our professional site visitors can now use our new search engine to easily find specific content and then legally use the content for such endeavors as research, marketing, corporate intelligence and public relations," said Alan Grofe, president. "We continue to significantly add resources for users of our MedBioWorld portal through such partners as Valeo IP with their cutting-edge digital rights solutions for our content partners."
Under the agreement, Healthnostics and Valeo IP also will jointly acquire news and journal publishing clients, many with local archived content databases to be included in the MedBioWorld site under a revenue sharing arrangement. User access to these new locally archived content databases will be available with the deployment of the expanded and enhanced Healthnostics portal www.medbioworld.com scheduled for the first quarter of 2005.
"On-line access to copyrighted content is very important to medical and bioscience professionals in order for them to stay abreast of the latest discoveries and newest information available," added Corey Johnson, President, Valeo IP. "In partnership with Healthnostics and medical and bioscience publishers, we are pleased to provide MedBioWorld users with the digital rights management tools needed to purchase specific articles or news items of interest to them on a per-document basis."
About Valeo IP
Valeo IP provides a full suite of content services including marketing tools like, custom reprints, digital licensing services and an online news clipping service; and Compliance tools like the Valeo IP Enterprise License that is sold to business users and allows for legal internal distribution of copyrighted works that are protected under the Valeo IP umbrella. Valeo IP helps publishers protect, license and track their intellectual property, and users to obtain the proper license to reprint or reuse copyrighted works in the format they desire. Valeo IP's users have legal access to articles from hundreds of online and printed publications, including The Associated Press, United Press International, VNU Business Media, Inc., PRIMEDIA Business, Reed Business Information, and Knight Ridder Digital. Valeo IP serves mores than 50,000 corporate and educational users in North America. For more information, visit www.ValeoIP.com.
About Healthnostics
Healthnostics, Inc. is a healthcare and bioscience information analytics and patient care improvement company. Healthnostics utilizes its Internet portals to deliver focused healthcare and bioscience information to industry professionals and the general public; and provides comprehensive patient clinical monitoring and improvement systems to hospitals nationwide. The company's strategic mission is to link its innovative DataQual patient monitoring and improvement systems with analytics clinical database systems, thus creating continuous-loop hospital strategic performance measurement feeding tactical clinical and pharmacology improvement hospital systems. Healthnostics medical and bioscience portals then provide the related news and journal research information necessary for completing the total information picture for medical and bioscience professionals and researchers, and the general public.
For further information please visit www.healthnostics.com, www.medbioworld.com, and www.familymedicalnet.com.
This announcement may contain, in addition to historical information, certain forward-looking statements that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.